Dr. Tashko’s infographic illustrating TSH functional zones maps thyroid-stimulating hormone levels across age and health contexts. The visual shows performance, protection, cognitive and pregnancy, and caution zones beneath a thyroid gland, emphasizing individualized targets. A rising TSH axis and age-related risk gradient highlight how optimal ranges shift for younger, active patients versus older or frail individuals.

Most laboratory reports present Thyroid Stimulating Hormone (TSH) as a single normal range. In real clinical care, that range behaves more like a curve. It shifts with age, cardiovascular risk, bone health, cognitive demands, pregnancy, and symptoms. The goal is not to chase a perfect number. The goal is to support physiology that functions well for the individual.

This is where the concept of thyroid “functional zones” becomes useful. Instead of treating all patients the same, we adjust targets based on biological context. This approach aligns better with how the body actually works.

The Concept in Brief

  • Younger adults often feel and function best with TSH in the lower-to-mid range, assuming free hormone levels are appropriate and overtreatment is avoided.
  • Older adults, especially those with atrial fibrillation risk, osteoporosis, or coronary disease, usually benefit from slightly higher TSH targets. Avoiding the low-end reduces real clinical harm.
  • Pregnancy and cognitive vulnerability may justify tighter control within age- or trimester-specific ranges. In these situations, thyroid hormone availability carries higher stakes.
  • Autoimmune thyroid disease patients may fall within the lab range yet remain symptomatic. For them, the most meaningful target is often the individual zone where symptoms stabilize.

Functional Zones in Practice

These zones are not rigid cutoffs. They serve as clinical signals.

  • The protection zone prioritizes safety. It applies to older adults or those with heart rhythm concerns or bone loss. In this setting, avoiding low TSH often matters more than achieving textbook values.
  • The performance zone suits younger individuals with higher cognitive or physical demands. Here, mid-to-lower TSH may support energy, focus, and metabolic efficiency, provided markers of overtreatment remain absent.
  • The pregnancy zone requires trimester-specific targets and close reassessment every four to six weeks. Thyroid needs change rapidly during this period.
  • The recovery zone applies after thyroiditis, weight changes, or recent dose adjustments. Stability matters most. Rapid swings often cause more harm than benefit.
Dr. Tashko’s infographic highlighting thyroid functional zones explains how TSH targets shift beyond standard laboratory ranges. The visual outlines protection, performance, and pregnancy zones alongside clinical strategies that prioritize patient context, symptom stability, and gradual dose adjustments. Icons of the thyroid, heart, cognition, and pregnancy emphasize individualized care across age, risk, and life stages.

How I Apply This Clinically

  1. Starting Point: I start with context. Age, symptoms, cardiovascular risk, bone density, pregnancy status, and cognitive needs guide every decision.
  2. Evaluation: I assess more than one number. TSH matters, but so do free T4, sometimes free T3, resting heart rate, rhythm history, bone health, and patient-reported symptoms.
  3. Adjustment: I adjust slowly. Thyroid hormone changes require patience. I reassess every six to eight weeks to avoid overshooting.
  4. Precision: I aim for the zone, not the edge. Suppression without a clear indication creates unnecessary risk.
  5. Long-Term Anchoring: Finally, I document each patient’s personal “feels-well window.” This becomes a reference point for future care.

When to Tighten or Loosen Targets

  • Lower targets may make sense during pregnancy or when persistent hypothyroid symptoms remain despite good adherence and absorption.
  • Higher targets are often safer in older adults, those with atrial fibrillation risk, osteoporosis, ischemic heart disease, or unintentional weight loss.

How I Explain This to Patients

“Your lab range is broad. For you, given your heart and bone health, we’ll stay slightly higher within that range to protect you. If you were younger with different goals, we might aim lower. The number serves the person, not the other way around.”

Dr. Tashko

  1. Reference Intervals in the Diagnosis of Thyroid Dysfunction: Treating Patients Not Numbers. The Lancet. Diabetes & Endocrinology. 2019. Jonklaas J, Razvi S.
  2. Thyroid Function Reference Intervals by Age, Sex, and Race : A Cross-Sectional Study. Annals of Internal Medicine. 2025. Li Q, Tang Y, Yu X, et al.
  3. Treating Hypothyroidism Is Not Always Easy: When to Treat Subclinical Hypothyroidism, TSH Goals in the Elderly, and Alternatives to Levothyroxine Monotherapy. Journal of Internal Medicine. 2022. Ross DS.
  4. Hypothyroidism. Lancet. 2024. Taylor PN, Medici MM, Hubalewska-Dydejczyk A, Boelaert K.
  5. Age-Specific Serum Thyrotropin Reference Range for the Diagnosis of Subclinical Hypothyroidism and Its Association With Lipid Profiles in the Elderly Population. Scientific Reports. 2022. Ni W, Zhang M, Wang X, et al.
  6. Hypothyroidism. The Journal of the American Medical Association. 2025. Chaker L, Papaleontiou M.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.